Research Progress in the Prevention and Treatment of Osteoporosis Using Chinese Medicinal Herb Eucommia ulmoides Oliver

Author:

Wang Hongze,Liu Geng,Bai Guoyang,Zan Qiang

Abstract

Osteoporosis (OP), a common bone metabolic disease in clinical practice, imposes a heavy burden on families and society due to the fragility fractures it causes. With the advent of an aging society, the prevention and treatment of OP has become a significant challenge worldwide. Currently, the treatment of OP primarily focuses on promoting bone formation and reducing bone loss. While these therapeutic approaches have clear goals and notable effects, they are still accompanied by certain toxic side effects. With the development of traditional Chinese medicine (TCM) in OP prevention and treatment, the therapeutic targets and mechanisms of action of TCM and its active ingredients are gradually gaining recognition. The traditional Chinese medicine Eucommia ulmoides (Du Zhong) and its prescriptions have demonstrated remarkable efficacy in clinically preventing and treating OP. In recent years, research on the anti-OP effects of Eucommia ulmoides and its active ingredients has become a hot topic, and their effectiveness has been confirmed. This article systematically reviews the research on Eucommia ulmoides extract, total lignans, iridoid glycosides, flavonoids, and their prescriptions, aiming to provide new perspectives for TCM in the field of OP prevention and treatment.

Publisher

Century Science Publishing Co

Reference30 articles.

1. Working Group for "Chinese Guidelines for the Diagnosis and Treatment of Osteoporosis in the Elderly (2023)", Osteoporosis Branch of the Chinese Geriatrics Society and Chinese Geriatric Medicine Society, Osteoporosis Branch of the China International Medical Exchange and Promotion Association, Osteoporosis Prevention and Rehabilitation Committee of the Chinese Association of Rehabilitation Medicine, Comprehensive Demonstration Research Group for Prevention and Control of Common Clinical Problems in the Elderly, Chinese Guidelines for the Diagnosis and Treatment of Osteoporosis in the Elderly (2023) [J]. Chinese Journal of Bone and Joint Surgery, 2023, (10): 865-885.

2. Chinese Pharmacopoeia [M]. Volume 1. 2020: 172.

3. Hu Yang, Li Xianzhi, Liu Yang, et al. Research Progress on Chemical Constituents, Pharmacological Effects, and Applications of Eucommia ulmoides [J]. Asia-Pacific Traditional Medicine, 2022, (02): 234-239.

4. Qi S, Zheng H, Chen C, Jiang H. Du-Zhong (Eucommia ulmoides Oliv.) Cortex Extract Alleviates Lead Acetate-Induced Bone Loss in Rats. Biol Trace Elem Res (BTER). 2019 Jan;187(1):172-180.

5. Lin J, Fan YJ, Mehl C, et al. Eucommia ulmoides Oliv. antagonizes H2O2-induced rat osteoblastic MC3T3-E1 apoptosis by inhibiting expressions of caspases 3, 6, 7, and 9. J Zhejiang Univ Sci B (JZUSB). 2011 Jan;12(1):47-54.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3